Please login to the form below
Artios Pharma
This page shows the latest Artios Pharma news and features for those working in and with pharma, biotech and healthcare.
UK biotech Artios Pharma appoints new medical director
Joins from senior role at Lilly. UK-based Artios Pharma has unveiled Dr Ian Smith, former Lilly and AstraZeneca clinical development leader, as its new chief medical officer. ... The Artios pipeline offers one of the most exciting approaches to cancer
Latest news
-
DNA damage specialists Artios Pharma raises $84m
Team behind development of Lynparza focus on next-gen DDR inhibitors. Cambridge, UK-based Artios Pharma has raised $84 million (£65 million) in a series B financing. ... Artios’ existing shareholders Arix Bioscience, SV Health Investors, M Ventures,
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
Latest appointments
-
Artios Pharma appoints science strategy VP
Francis Crick Institute lead Dr Simon Boulton joins management team. Cambridge, UK-based Artios Pharma has appointed Dr Simon Boulton as vice president of science strategy. ... He brings over 20 years of expertise in DNA repair and the treatment of
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
Featured jobs
-
Account Director – UK Office
-
Excellent salary and benefits
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
- Account Director, Healthcare Communications
-
Salary TBC
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
Subscribe to our email news alerts
- Finch Therapeutics bags $53m for microbiome therapies
- MSD taps Austria’s Themis to bolster vaccine pipeline
- Early ‘no’ for GW Pharma’s epilepsy drug, but NICE vows to collaborate
- GSK preps filings for BCMA-targeting multiple myeloma drug
- Behaviour change – is there something missing?
- NICE’s long-serving chief exec Sir Andrew Dillon to step down
PMHub
Novasecta
We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...
Latest intelligence
- Empowered patients: shaking the foundations of healthcare
- Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
- A uniquely English genomic medicine service
- The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
Quick links
Infographics
